Recursion Pharmaceuticals, Inc.
看多

daily support level, mean reversion rebound

371
daily supp level

nvda earnings in AH

price action speaks itself, upside break of trendline and lower vwap band, H&S

mean reversion rebound play with huge potential to be runners if RXRX decide to breakout of its current trading range

bad news overpriced while merger news' full implication on price has yet to be captured

no at bad price to stock up

etc

What do you think?
註釋
wait for sustained upside break of trendline and lower vwap band to signal entry, else no entry

免責聲明

這些資訊和出版物並不意味著也不構成TradingView提供或認可的金融、投資、交易或其他類型的意見或建議。請在使用條款閱讀更多資訊。